weakness and malaise required rest (50%) were the most common AE and vomiting (20%) as well as fever (20%) were the second common.
Methods: MDR-TB patients who were treated at Seoul National Hospital University between 1996 and 2015 were divided by five years according to the date of initial diagnosis. The changes of demographic characteristics, drug resistance, drugs used , treatment outcomes, and adverse events over time was evaluated using nonparametric test for trend across ordered groups. cohort 4 (P = 0.007). The proportion of patients with positive acid-fast bacilli staining of sputum (from 60.5 to 29.7%, P < 0.001) or cavities (from 86.0% to 40.5%, P < 0.001) on chest radiographs decreased over time.
Resistance to pyrazinamide, fluoroquinolone, cycloserine, and paminosalicylic acid decreased over time. For treatment, later-generation fluoroquinlone (from 77.9 to 90.5%) and linezolid (from 0 to 26.2%) were more frequently prescribed recently. The treatment success rate increased from 45.3 to 88.1% over 20 years (P < 0.001). However, neurologic adverse events including peripheral neuropathy increased from 4.7 to 13.1% (P = 0.027). no contact with pre/XDR TB patients; no exposure for ≥1 months to second-line medicines in the STR; no intolerance to medicines in the STR; no pregnancy; no severe extra pulmonary TB; no severe lung defect with underweight BMI. Indonesia started to implement the STR since October 2017 where the target aimed was 80% of MDR-TB patients received the STR. The purpose of the study is to evaluate the eligibility of MDR TB patients to be given STR as the first choice of regimen as recommended by WHO, applied by Dr. Soetomo Hospital, which is the centre of East Indonesian MDR-TB referral hospital.
Conclusion
Methods: This was a descriptive study. From the data of registry, we analyzed phenotypic DST results to the constituent drugs, taking history, laboratory and chest X-Ray of all RR cases diagnosed based on gene Xpert in, from October 2017 to July 2018, to determine their eligibility for this regimen. are 17 (37.8%) patients are resistant to fluoroquinolon/ second-line injectable drugs, 1 (2.2%) is exposured for ≥1 months to second-line medicines, 1 (2.2%) has contact with XDR patients, 2 (3.4%) are intolerance to medicines in the STR, and 24 (53,3%) have severe lung defect with underweight BMI.
Conclusions: There are 105 (70%) patients are eligible to STR and 45 (30%) are ineligible from total 150 RR/MDR TB patients. The major cause of ineligibility in this study is due to the severe lung defect with underweight BMI.
Keywords: MDR-TB, Shorter Regimen. Background and Aims: Empyema is a complication of a prapneumonic effusion. Chylothorax is caused by traumatic and non-trumatic aetiologies. Secondary spontaneous pneumothorax occurs in those with pulmonary diseases. An aetiology which can cause the occurrence of all these three diseases is PTB. Reports of an exudative effusion fulfilling the criteria for both chylothorax and empyema, complicated with pneumonthorax, on the background of PTB, are rare.
Methods:
We report the case of a patient with infected chylothorax and pneumothorax secondary to PTB.
Results: A 76-year-old, male, with a complaint of cough, dyspnea and weight loss. Medical history was significant for hypertension, diabetes and COPD. Physical examination revealed crackles heard on the right lung and decreased breath sounds on the left. The intercostal tube drained 0 to 200 cc of non-foul-smelling, turbid, milky fluid per day. HIV test was negative. CXR and chest CT showed multiple bilateral pulmonary nodules, cavitations, pneumonia with consolidation and pneumohydrothorax on the left. Upon centrifugation, the pleural fluid remained milky. Pleural fluid analysis yielded an exudative effusion with the following results: pH 6.5, wbc 5.9 × 10 9 , lymphocytes 76%, glucose, total cholesterol 23 mg/dl, TG 17 mg/dl. Pleural fluid/serum cholesterol ratio was 0.18, while pleural fluid/serum TG was 0.11. Pleural fluid culture grew Acinetobacter sp. Pleural fluid and endotracheal aspirate TB culture were positive for Mycobacterium tuberculosis. No evidence of malignancy was detected after thorough investigation. He was started on antibiotics and anti-TB therapy.
The coexistence of empyema and chylothorax is rare because of the bacteriostatic nature of chyle, more so is TB as a cause of chylothorax. In
Respirology ( 
